2021 Clinical Application Series

Contact Hours : 5 + more
Start Date :  Apr 20, 2021End Date :  Oct 19, 2021

Organized by :   College of Psychiatric and Neurologic Pharmacists (CPNP)

Specialties :   Medical Education

Fees Fee :   Starting From USD 80

Conference Summary

2021 Clinical Application Series is organized by College of Psychiatric and Neurologic Pharmacists (CPNP).

Activity Dates: 04/20/2021 - 10/19/2021

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 5 hours of ACPE credit and 5 hours of BCPP Recertification credit by successfully completing the online Clinical Application Series examination.

Learning Objectives:
Antipsychotic Adverse Effects Comparison:
• Analyze the relationship between receptor binding affinities and the adverse effect profiles of antipsychotics.
• Compare the antipsychotics based on their adverse effect profiles.
• Select the most appropriate antipsychotic for a patient based on adverse effect potential and past medical history.
Harm Reduction Strategies in Opioid Use Disorder:
• Assess the utility of harm reduction strategies for patients with opioid use disorder.
• Advocate for harm reduction strategies for patients with opioid use disorder based on ethical and legal considerations.
• Propose strategies to implement evidence-based harm reduction programs for patients with opioid use disorder.
 Role of Newer Antidepressants in Social Anxiety Disorder (SAD):
• Evaluate a patient for social anxiety disorder using validated screening tools.
• Compare the efficacy and/or adverse effects of current treatment options for social anxiety disorder.
• Assess the role of newer antidepressants in the treatment of social anxiety disorder.
• Develop a pharmacologic treatment plan for the management of social anxiety disorder.
Pharmacologic Management of Insomnia with Sleep Apnea:
• Assess how use of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea and co-morbid insomnia affects sleep.
• Evaluate the risks and benefits of sedative hypnotics for treatment of insomnia in patients with co-morbid obstructive sleep apnea.
• Create a pharmacologic treatment plan for management of insomnia in a patient with co-morbid obstructive sleep apnea who has tried and failed non-pharmacologic interventions.
Management of Acute Repetitive Seizures: 
• Assess a patient with epilepsy for risk factors and symptoms that meet clinical presentation for acute repetitive seizures (ARS) and status epilepticus (SE).
• Recommend an appropriate rescue treatment for a patient at risk for ARS and SE based on the clinical literature and specific patient factors.
• Educate patients with epilepsy and their caregivers on the administration and monitoring of treatments for ARS.

Credit Info

  • Contact Hours : 5
  • Hours : 5
Contact Us

Toll free Number

1(800) 826-2059



Chat Assistant

Live Chat